The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: A multicenter, prospective, open-label, observational study in Korea

Abstract

Empirical antifungal therapy; Hematological malignancy; Hydroxy itraconazole; itraconazole; Therapeutic drug monitoring